Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2019 | 10-2018 | |
| Operating Expenses | 80 | 194 |
| Operating Income | -80 | -194 |
| Other Income | 0 | 46 |
| Pre-tax Income | -80 | -148 |
| Net Income Continuous | -80 | -148 |
| Net Income | $-80 | $-148 |
| EPS Basic Total Ops | -9.00 | -18.00 |
| EPS Basic Continuous Ops | -9.00 | -18.00 |
| EPS Diluted Total Ops | -9.00 | -18.00 |
| EPS Diluted Continuous Ops | -9.00 | -18.00 |
| EBITDA(a) | $-80 | $-194 |